Unibio KSA ApS: Financial statements 2022
CVR: 40762272
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Unibio KSA ApS (CVR 40762272) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -18,000 and a net result of DKK -21,000 compared with DKK -11,000 the year before. Equity in the 2022 report amounted to DKK 56,000. The solvency ratio was 82.4%.
- Gross Profit
- DKK -18,000
- Profit/Loss
- DKK -21,000
- Equity
- DKK 56,000
- Total Assets
- DKK 68,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -18 t. | -21 t. | 56 t. | 0 |
| 2021 | - | -14 t. | -11 t. | 27 t. | 0 |
Official annual report
Keep an eye on Unibio KSA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Unibio KSA ApS has published its annual report for 2021. Gross profit came to DKK -14,000, and the net result was DKK -11,000.
About Unibio KSA ApS
Unibio KSA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of David Richard Henstrom and Jess Dragheim. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -383,000 compared with DKK -107,000 the year before. Equity in the 2025 report amounted to DKK -793,000.